Media ReleasesLBT Innovations

View All LBT Innovations News

LBT Innovations - Non-Renounceable Rights Issue

Adelaide, Australia, 25 October 2022: Australian medical technology company LBT Innovations Limited (ASX: LBT) (LBT or the Company) a leader in medical technology automation using artificial intelligence, is pleased to announce that it will be conducting a pro rata non-renounceable entitlement offer to existing eligible shareholders.

The Company is seeking to raise up to approximately $3.5 million (before costs) through the offer of 1 new fully paid ordinary share in the capital of the Company (Share) for every 6 Shares held by eligible shareholders at an issue price of $0.065 per Share, plus 1 free attaching option for every 3 new Shares subscribed for (Option) (collectively, the Entitlement Offer).

Key Points

-- $3.5m Non-Renounceable Entitlement Offer on a 1 for 6 basis
-- 1 Option for every 3 new Shares subscribed for under the Entitlement Offer
-- Funds from the Offer will be used to support expected sales growth and finalisation of the core offering of Analysis Modules which will extend the utility of the APAS® Independence
-- Ability for Eligible Shareholders to apply for additional Shares on the same terms as the Entitlement Offer
-- Prospectus for the Entitlement Offer to be lodged today

For more information, download the attached PDF.

Download this document

Subscribe to our Daily Newsletter?

Would you like to receive our daily news to your inbox?